Members

Blog Posts

LED Bulb Market Size, Share, Growth Factors and Forecast 2024-2032

Posted by mark smith on August 22, 2024 at 5:36am 0 Comments

The latest report by IMARC Group, titled “LED Bulb Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2032,” offers a comprehensive analysis of the LED bulb market growth. The report also includes competitor and regional analysis, along with a breakdown of segments within the industry.

The global LED bulb market size reached US$ 9.2 Billion in 2023.…

Continue

The Mirage of Wonders Debunking the Statements

Posted by Khalid Shaikh on August 22, 2024 at 5:31am 0 Comments

A "course in wonders is false" is a daring assertion that will require a deep jump in to the statements, viewpoint, and affect of A Course in Miracles (ACIM). ACIM, a religious self-study program published by Helen Schucman in the 1970s, presents itself as a spiritual text that aims to greatly help individuals obtain inner peace and religious transformation through a series of instructions and a comprehensive philosophical framework. Authorities fight that ACIM's basis, methods, and email… Continue

Rheumatoid Arthritis Industry Share at USD, Key Company’s Profiles and Forecast to 2030

Rheumatoid arthritis Market Overview:

During old age, rheumatoid arthritis problem is common. And smokers are more prone to it. Contrary to popular belief, rheumatoid arthritis goes beyond joint pain. Sometimes, it can also damage various parts of the body system that include blood vessels, eyes, heart, lungs, and skin. Therefore, the rheumatoid arthritis market is growing.

Market Research Future (MRFR) has published a research report that predicts success for the global Rheumatoid Arthritis Market Overview with 4% CAGR (Compound Annual Growth Rate) between 2022 and 2030. Analyzing the market structure, this report evaluates the future growth potential and observes the strategies of the key players in this market. It also tracks the competitive developments such as joint ventures, mergers, and acquisitions, new product developments, new product developments (R & D) in the market. According to a study, the women are three times more prone to this disease than men. The key factors that can impact the market growth include a high number of individuals suffering from the autoimmune disease.

Key Players:

The key players in the global Rheumatoid Arthritis Market Players include AstraZeneca (UK), Bristol-Myers Squibb Company (USA), Eli Lilly and Company (USA), F. Hoffmann-La Roche Ltd (Switzerland), Novartis AG (Switzerland), Pfizer Inc (USA), Sanofi (France), and Vertex Pharmaceuticals Incorporated (USA).

Segmentation:

The global Rheumatoid Arthritis Market Report has been segmented on the basis of diagnosis, drug type, treatment, and lastly, region. Based on the diagnosis, the market has been segmented into the C-Reactive Protein (CRP) Test, cyclic citrullinated peptide (CCP), and erythrocyte sedimentation rate (ESR) test. By drug types, the market has been segmented into biologic agents, Disease-modifying anti-rheumatic drug type (DMARDs), Non-steroidal anti-inflammatory drug type (NSAID), and steroids. The treatment-based market segmentation covers joint fusion, synovectomy, and tendon repair. Joint fusion welds the bones to relieve joint pain. Via synovectomy, the synovial tissue surrounding a joint is removed. Tendon repair is surgery required for treating a torn or damaged tendon.

Regional Analysis:

The regional segmentation of the global Rheumatoid Arthritis Market segments the market into regional markets namely North America, Europe, Asia Pacific, and the Middle East & Africa. North America is the biggest market due to advanced medical facilities being available here, and it is expected to grow during the forecast period. The cream of this market comprises of the United States of America (USA) and Canada. Europe, the second largest market for rheumatoid arthritis is also expected to grow during the forecast period. After North America, Europe has maximum advanced medical facilities. Maximum revenue of this market comes from France, Germany, Italy, Spain, and the United Kingdom (UK), followed by the rest of Europe.

Asia Pacific market is expected to be the fastest growing market for rheumatoid arthritis during the forecast period due to medical facilities improving in this region with growing urbanization and steady technological advancement that is giving rise to medical tourism in Asia Pacific region. The biggest share in the Asia Pacific region is commanded by Australia, China, India, Japan, and South Korea, followed by the rest of Asia Pacific. MEA region is the smallest regional market. Due to lack of education, less infrastructure development, limited growth in the healthcare sector, and political instability, the market is low in this region. Maximum revenue for this market is generated by Egypt, Saudi Arabia, South Africa, and United Arab Emirates (UAE), followed by rest of the MEA region.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Views: 5

Comment

You need to be a member of On Feet Nation to add comments!

Join On Feet Nation

© 2024   Created by PH the vintage.   Powered by

Badges  |  Report an Issue  |  Terms of Service